Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04550026 |
Other study ID # |
2020-03387 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 1, 2020 |
Est. completion date |
April 1, 2021 |
Study information
Verified date |
October 2021 |
Source |
Karolinska Institutet |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This is a human randomized controlled cross-over study where the effects of heated tobacco
products (HTP) on vascular function, microcirculation and thrombosis is assessed.
Description:
The World Health Organization estimates that smoking is one of the leading causes of
premature death worldwide with an estimated 5-8 million lives lost annually due to tobacco
usage (1).
Heated tobacco products (HTP) is a new form of tobacco products. HTP usually consists of a
pod with tobacco that is mixed with glycerol which is inserted into a heating chamber. HTP is
not combusted but only heated (2). Previous studies into smoking cessation with regular
cigarettes and electronic cigarettes have suggested a risk for double usage instead of
cessation, augmenting a nicotine addiction (3-5). There is a risk that HTP use simply
enhances nicotine usage and smoking addiction.
There is limited data on the health effects of HTP. A majority of the studies available have
reported conflicts of interest to manufacturers of HTP (11). It has been shown that aerosols
from HTP contain toxic compounds and free radicals just as in regular cigarette smoke, albeit
in lower concentrations (6-8). Furthermore, aerosols from HTP can spread in a room, enabling
passive exposure (9). It has been shown that there is a decrease in harmful biomarkers in
smokers that switch to HTP after 5 days of usage but also of a higher HTP consumption
compared to regular smoking (12). There are few studies on effects of HTP in humans.
Nabavizadeh et al has shown impaired endothelial function in rats after exposure to IQOS
(10).
_____________
Subjects and criteria:
Thirty male or female occasional tobacco users (age 18-40, maximum 10 cigarettes per month or
10 pouches of snus per month) will be included. They have to be healthy, having no
preexisting conditions or take any medications. All subjects will have to complete a normal
health declaration.
Methods:
In randomized cross-over fashion subjects will either inhale vapor (1 puff per minute for 30
minutes, total 30 puffs) from a HTP of the brand IQOS (IQOS 3 Multi, Philip Morris AB) or
perform sham-smoking of HTP. Measurements of arterial stiffness is performed previous, during
and 60 minutes following exposures. Blood samples will be collected at baseline for cotinine,
measurement with T-TAS, endothelial progenitor cells (EPC), NETs and extracellular vesicles
(EV). Blood samples will be drawn up to 3 hours post-exposure (EPC, T-TAS,EV, NETs).
Microcirculation is evaluated at baseline with skin capillaroscopy and Laser-Speckle contrast
imaging (LSCI) and at 1 hour post-exposure.
Measurement of vascular function Arterial stiffness (Sphygmocor) Increased arterial stiffness
is recognized as a major factor in vascular aging and a risk factor for cardiovascular
disease (13). Arterial stiffness will be assessed by pulse wave analysis and pulse wave
velocity.
Photopletysmography (PPG) Finger photoplethysmography is another method that provides
information on the arterial bloodflow which allows measurement of pulse propagation time
(PPT) (14).
Measurement of microcirculation Microcirculation will be assessed by several methods. Skin
perfusion is investigated through Laser Speckle contrast Imaging , which is an optical
technique for assessment of skin flux, i.e movement of circulating red blood cells. This
method measures overall skin flux in superficial arterioles, capillaries and venules over
wide skin areas and with a high frequency. Iontophoresis is a non-invasive method for drug
application across the skin using a small electric current. Acetylcholine (ACh, Sigma-Aldrich
AB, Stockholm, Sweden) and sodium nitroprusside (SNP, Hospira, Inc., Lake Forest, IL, USA),
both diluted in 9% physiological sodium chloride solutions, are used to investigate
endothelium-dependent and endothelium-independent microvascular reactivity, respectively.
Electrode chambers (LI611 Drug Delivery Electrode, Perimed, Järfälla, Sweden) are attached to
the volar side of the left forearm, avoiding hair, broken skin and visible veins, and filled
with a small volume of either ACh (2%) or SNP (2%). A battery-powered iontophoresis
controller (Perilont LI 760; Perimed, Järfälla, Sweden) provides a single dose of 0.02 mA for
200 seconds for drug iontophoresis. ACh is delivered using an anodal charge and SNP with a
cathodal charge. LSCI (PeriCam PSI NR; Perimed, Järfälla, Sweden) is used to assess skin
microvascular flux continuously before, during and 15 minutes after iontophoresis.
Skin capillaroscopy is another method for evaluating the microcirculation. A USB microscope
(CapillaryScope 500 pro, Dino-Lite®) is used to visualize nail fold capillaries in the finger
(preferably 4th digit of left hand). Capillaries with good optical signals, i.e. with visible
red blood cell movements and plasma gaps, are chosen for examination. Capillary blood flow is
registered continuously at rest, during and after one-minute arterial occlusion at the
proximal phalanx of the digit with a suprasystolic cuff pressure. Calculation of capillary
blood cell velocity (CBV, mm/s) is done off line and will generate following four variables:
rCVB (mean CBV at rest), pCVB (peak CBV following one-minute arterial occlusion), time to
peak (time (s) from release of cuff pressure to peak flow, and post-occlusive reactive
hyperemia (precentral increase of CBV from rest to peak flow).
Blood pressure:
A semi-automatic oscillometric sphygmomanometer will be used to measure blood pressure and
heart rate.
Blood sampling Blood samples will be drawn into test tubes containing 1/10 0.129 M sodium
citrate, EDTA and serum at baseline, at 2 hour and 4 hours after exposure. Plasma is later
collected after centrifugation at 2 000g for 20 min in room temperature (RT) and then frozen
at -70°C until analysis.
Measurement of thrombus formation (T-TAS) T-TAS® (Total Thrombus-formation Analysis System)
is a means of assessing thrombus formation during variable flow conditions using a small
blood sample.
Measurement of cotinine Measurement is done to ensure adherence that subjects have not used
tobacco in the last 7 days. Levels of cotinine will be measured in serum using a commercial
available ELISA technique.
Measurement of EPCs The number of EPCs will be measured in whole blood by flow cytometry.
EPCs are measured as CD34+ KDR+ (KDR: vascular endothelial growth factor receptor 2) double
positive cells. Briefly, 20 µl of whole blood is incubated with CD34-FITC (Beckman Coulter,
Brea, CA, USA) and CD309 (Becton Dickinson, Franklin Lakes, New Jersey, USA). Conjugate
isotype-matched immuno-globulin (IgG1-FITC, IgG1-PE) with no reactivity against human
antigens are used as a negative control. After 30 minutes of incubation in a dark
environment, BD cell-fix is added to fixate the samples. Twenty thousand events of leukocytes
are collected (based on classical forward scatter/side scatter (size/granularity)
characteristics of blood leukocytes) and results will be presented as a number of EPC events.
Measurement of Extracellular Vesicles Plasma is thawed and centrifuged at 2000g for 20
minutes at RT. The supernatant is then re-centrifuged, at 13 000g for 2 minutes at RT. 20 µl
of sample is incubated for 20 minutes in dark with phalloidin-Alexa-660 (Invitrogen, Paisley,
UK), lactadherin-FITC (Haematologic Technologies, Vermont, USA), CD42a-PE (Platelet-MP (PMP),
BD, Clone Alma-16), CD45-PC7 (Leukocyte-EV (LEV), Beckman Coulter, Dublin, Ireland) and
CD144-APC (Endothelial-EV (EEV), AH diagnostics, Stockholm, SWE). PEVs are also labeled with
CD154-PE (CD40L, abcam, Cambridge, UK) and EEVs with CD62E (E-selectin, Beckman Coulter,
Dublin, Ireland). EVs are measured by flow cytometry on a Beckman Gallios instrument (CA,
USA). The EV-gate is determined using Megamix beads (BioCytex, Marseille, France), which is a
mix of beads of with diameters of 0.5 µm, 0.9 µm and 3.0 µm, respectively. EVs are defined as
particles less than 1.0 µm in size, negative to phalloidin (in order to exclude cell membrane
fragments) and positive to lactadherin. Conjugate isotype-matched immunoglobulin (IgG1-FITC,
IgG1-PE, IgG1-APC and IgG1- PC7) with no reactivity against human antigens is used as a
negative control to define the background noise of the cytometric analysis. The absolute
number of EVs is calculated by means of the following formula: (EV counted x standard beads ⁄
L) ⁄ standard beads counted, (FlowCount, Beckman Coulter).
__________________
References
1. World Health Organization, & Others. (2019). WHO Report on the Global Tobacco Epidemic,
2019. Geneva: World Health Organization; 2019. Google Scholar.
2. Smith, M. R., Clark, B., Lüdicke, F., Schaller, J.-P., Vanscheeuwijck, P., Hoeng, J., &
Peitsch, M. C. (2016). Evaluation of the Tobacco Heating System 2.2. Part 1: Description
of the system and the scientific assessment program. Regulatory Toxicology and
Pharmacology: RTP, 81 Suppl 2, S17-S26.
3. Lee, S., R.A. Grana, and S.A. Glantz, Electronic Cigarette Use Among Korean Adolescents:
A Cross-Sectional Study of Market Penetration, Dual Use, and Relationship to Quit
Attempts and Former Smoking. J Adolesc Health, 2013.
4. Caponnetto, P., et al., Impact of an electronic cigarette on smoking reduction and
cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ
Res Public Health, 2013. 10(2): p. 446-61.
5. Polosa, R., et al., Effect of an electronic nicotine delivery device (e-Cigarette) on
smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health,
2011. 11: p. 786.
6. Bekki, K., Inaba, Y., Uchiyama, S., & Kunugita, N. (2017). Comparison of chemicals in
mainstream smoke in heat-not-burn tobacco and combustion cigarettes. Journal of UOEH.
https://doi.org/10.7888/juoeh.39.201
7. Shein, M., & Jeschke, G. (2019). Comparison of Free Radical Levels in the Aerosol from
Conventional Cigarettes, Electronic Cigarettes, and Heat-Not-Burn Tobacco Products.
Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.9b00085
8. Ruprecht, A. A., De Marco, C., Saffari, A., Pozzi, P., Mazza, R., Veronese, C., … Boffi,
R. (2017). Environmental pollution and emission factors of electronic cigarettes,
heat-not-burn tobacco products, and conventional cigarettes. Aerosol Science and
Technology. https://doi.org/10.1080/02786826.2017.1300231
9. Mitova, M. I., Campelos, P. B., Goujon-Ginglinger, C. G., Maeder, S., Mottier, N.,
Rouget, E. G. R. Tricker, A. R. (2016). Comparison of the impact of the Tobacco Heating
System 2.2 and a cigarette on indoor air quality. Regulatory Toxicology and
Pharmacology. https://doi.org/10.1016/j.yrtph.2016.06.005
10. Nabavizadeh, P., Liu, J., Havel, C. M., Ibrahim, S., Derakhshandeh, R., Jacob, P., &
Springer, M. L. (2018). Vascular endothelial function is impaired by aerosol from a
single IQOS HeatStick to the same extent as by cigarette smoke. Tobacco Control.
https://doi.org/10.1136/tobaccocontrol-2018-054325
11. Simonavicius, E., McNeill, A., Shahab, L., & Brose, L. S. (2019). Heat-not-burn tobacco
products: A systematic literature review. Tobacco Control.
https://doi.org/10.1136/tobaccocontrol-2018-054419
12. Yuki, D., Takeshige, Y., Nakaya, K., & Futamura, Y. (2018). Assessment of the exposure
to harmful and potentially harmful constituents in healthy Japanese smokers using a
novel tobacco vapor product compared with conventional cigarettes and smoking
abstinence. Regulatory Toxicology and Pharmacology.
https://doi.org/10.1016/j.yrtph.2018.05.001
13. Mahmud, A., & Feely, J. (2003). Effect of smoking on arterial stiffness and pulse
pressure amplification. Hypertension. https://doi.org/10.1161/01.HYP.0000047464.66901.60
14. Sommermeyer, D., Zou, D., Ficker, J. H., Randerath, W., Fischer, C., Penzel, T., …
Grote, L. (2016). Detection of cardiovascular risk from a photoplethysmographic signal
using a matching pursuit algorithm. Medical and Biological Engineering and Computing.
https://doi.org/10.1007/s11517-015-1410-8
15. Mahmud, A., & Feely, J. (2003). Effect of smoking on arterial stiffness and pulse
pressure amplification. Hypertension, 41(1), 183-187.